Ivan Stamenkovic

36.2k total citations · 11 hit papers
157 papers, 24.7k citations indexed

About

Ivan Stamenkovic is a scholar working on Molecular Biology, Cell Biology and Immunology and Allergy. According to data from OpenAlex, Ivan Stamenkovic has authored 157 papers receiving a total of 24.7k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Molecular Biology, 51 papers in Cell Biology and 47 papers in Immunology and Allergy. Recurrent topics in Ivan Stamenkovic's work include Proteoglycans and glycosaminoglycans research (47 papers), Cell Adhesion Molecules Research (47 papers) and Glycosylation and Glycoproteins Research (41 papers). Ivan Stamenkovic is often cited by papers focused on Proteoglycans and glycosaminoglycans research (47 papers), Cell Adhesion Molecules Research (47 papers) and Glycosylation and Glycoproteins Research (41 papers). Ivan Stamenkovic collaborates with scholars based in United States, Switzerland and Italy. Ivan Stamenkovic's co-authors include Qin Yu, Brian Seed, Alejandro Aruffo, Nicolò Riggi, Charles B. Underhill, Michael Melnick, Martine Amiot, Fred T. Bosman, Paolo Provero and Mario-Luca Suvà and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Ivan Stamenkovic

156 papers receiving 24.0k citations

Hit Papers

CD44 is the principal cell surface receptor for hyaluronate 1984 2026 1998 2012 1990 2000 2000 2003 1992 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivan Stamenkovic United States 77 12.6k 6.3k 5.6k 5.1k 4.9k 157 24.7k
Bengt Westermark Sweden 86 16.4k 1.3× 4.0k 0.6× 3.5k 0.6× 5.4k 1.1× 4.2k 0.9× 340 29.1k
Karl Tryggvason Sweden 96 15.1k 1.2× 4.9k 0.8× 4.1k 0.7× 4.8k 0.9× 6.8k 1.4× 384 34.3k
Daniel B. Rifkin United States 92 17.5k 1.4× 5.5k 0.9× 3.0k 0.5× 4.2k 0.8× 6.7k 1.4× 230 32.7k
Dietmar Vestweber Germany 101 13.9k 1.1× 4.4k 0.7× 9.2k 1.6× 4.5k 0.9× 2.5k 0.5× 323 30.1k
Michael Klagsbrun United States 103 26.1k 2.1× 8.5k 1.3× 3.8k 0.7× 8.1k 1.6× 6.8k 1.4× 272 38.9k
M. Luisa Iruela‐Arispe United States 82 12.5k 1.0× 3.2k 0.5× 2.8k 0.5× 3.1k 0.6× 5.0k 1.0× 202 21.4k
Jun‐Lin Guan United States 78 13.2k 1.0× 7.3k 1.2× 2.3k 0.4× 3.3k 0.6× 3.6k 0.7× 202 24.9k
Joseph A. Madri United States 85 8.6k 0.7× 2.9k 0.5× 3.3k 0.6× 2.2k 0.4× 3.6k 0.7× 241 21.0k
Ismo Virtanen Finland 75 8.3k 0.7× 5.1k 0.8× 2.3k 0.4× 3.2k 0.6× 2.0k 0.4× 480 20.7k
Filippo G. Giancotti United States 67 9.0k 0.7× 6.2k 1.0× 2.1k 0.4× 4.4k 0.9× 3.0k 0.6× 115 18.5k

Countries citing papers authored by Ivan Stamenkovic

Since Specialization
Citations

This map shows the geographic impact of Ivan Stamenkovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Stamenkovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Stamenkovic more than expected).

Fields of papers citing papers by Ivan Stamenkovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Stamenkovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Stamenkovic. The network helps show where Ivan Stamenkovic may publish in the future.

Co-authorship network of co-authors of Ivan Stamenkovic

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Stamenkovic. A scholar is included among the top collaborators of Ivan Stamenkovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Stamenkovic. Ivan Stamenkovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Colombo, Daniele, Rajendran Sanalkumar, Liliane C. Broye, et al.. (2024). Preclinical spheroid models identify BMX as a therapeutic target for metastatic MYCN nonamplified neuroblastoma. JCI Insight. 9(14).
2.
Sanalkumar, Rajendran, Rui Dong, Yu‐Hang Xing, et al.. (2023). Highly connected 3D chromatin networks established by an oncogenic fusion protein shape tumor cell identity. Science Advances. 9(13). 17 indexed citations
3.
Riggi, Nicolò, Luisa Cironi, & Ivan Stamenkovic. (2018). Synovial sarcoma: when epigenetic changes dictate tumour development. Swiss Medical Weekly. 148(4748). w14667–w14667. 12 indexed citations
4.
Galland, Sabine, Patricia Martin, Igor Letovanec, et al.. (2017). Tumor-Derived Mesenchymal Stem Cells Use Distinct Mechanisms to Block the Activity of Natural Killer Cell Subsets. Cell Reports. 20(12). 2891–2905. 90 indexed citations
5.
Riggi, Nicolò, et al.. (2014). Targeting Cancer Stem–like Cells as an Approach to Defeating Cellular Heterogeneity in Ewing Sarcoma. Cancer Research. 74(22). 6610–6622. 24 indexed citations
6.
Xu, Yin, Ivan Stamenkovic, & Qin Yu. (2010). CD44 Attenuates Activation of the Hippo Signaling Pathway and Is a Prime Therapeutic Target for Glioblastoma. Cancer Research. 70(6). 2455–2464. 176 indexed citations
7.
Janiszewska, Michalina, Claudio De Vito, Marie‐Aude Le Bitoux, Carlo Fusco, & Ivan Stamenkovic. (2010). Transportin Regulates Nuclear Import of CD44. Journal of Biological Chemistry. 285(40). 30548–30557. 39 indexed citations
8.
Suvà, Mario-Luca, Nicolò Riggi, Michalina Janiszewska, et al.. (2009). EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance. Cancer Research. 69(24). 9211–9218. 379 indexed citations
9.
Suvà, Mario-Luca, Nicolò Riggi, Jean‐Christophe Stehle, et al.. (2009). Identification of Cancer Stem Cells in Ewing's Sarcoma. Cancer Research. 69(5). 1776–1781. 243 indexed citations
10.
Riggi, Nicolò, Mario-Luca Suvà, Domizio Suvà, et al.. (2008). EWS-FLI-1 Expression Triggers a Ewing's Sarcoma Initiation Program in Primary Human Mesenchymal Stem Cells. Cancer Research. 68(7). 2176–2185. 259 indexed citations
11.
Riggi, Nicolò, Luisa Cironi, Paolo Provero, et al.. (2006). Expression of the FUS-CHOP Fusion Protein in Primary Mesenchymal Progenitor Cells Gives Rise to a Model of Myxoid Liposarcoma. Cancer Research. 66(14). 7016–7023. 115 indexed citations
12.
Riggi, Nicolò, Luisa Cironi, Paolo Provero, et al.. (2005). Development of Ewing's Sarcoma from Primary Bone Marrow–Derived Mesenchymal Progenitor Cells. Cancer Research. 65(24). 11459–11468. 279 indexed citations
13.
Bosman, Fred T. & Ivan Stamenkovic. (2003). Preface to extracellular matrix and disease. The Journal of Pathology. 200(4). 421–422. 4 indexed citations
15.
Biancone, Luigi, Giuseppe A. Andres, H. Ahn, et al.. (1996). Distinct regulatory roles of lymphocyte costimulatory pathways on T helper type-2 mediated autoimmune disease.. The Journal of Experimental Medicine. 183(4). 1473–1481. 54 indexed citations
16.
Nelson, Richard M., et al.. (1995). Carbohydrate-Protein Interactions in Vascular Biology. Annual Review of Cell and Developmental Biology. 11(1). 601–631. 93 indexed citations
17.
Sgroi, Dennis C. & Ivan Stamenkovic. (1994). The B‐Cell Adhesion Molecule CD22 is Cross‐Species Reactive and Recognizes Distinct Sialoglycoproteins on Different Functional T‐Cell Sub‐Populations. Scandinavian Journal of Immunology. 39(5). 433–438. 16 indexed citations
18.
Fenderson, Bruce A., Ivan Stamenkovic, & Alejandro Aruffo. (1993). Localization of hyaluronan in mouse embryos during implantation, gastrulation and organogenesis. Differentiation. 54(2). 85–98. 73 indexed citations
19.
Aruffo, Alejandro & Ivan Stamenkovic. (1991). The Hyaluronate Receptor (CD44).. Trends in Glycoscience and Glycotechnology. 3(13). 334–342. 3 indexed citations
20.
Stamenkovic, Ivan, et al.. (1990). The B cell antigen CD75 is a cell surface sialytransferase.. The Journal of Experimental Medicine. 172(2). 641–643. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026